Chronic Disease Management Service - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510241186

Publication Date:

October 31, 2024

Pages:

110

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Chronic disease management services are also referred as enhance primary care. This service is provided to the patient suffering from the chronic or terminal health condition and require multidisciplinary care.
The global market for Chronic Disease Management Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Disease Management Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Disease Management Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Chronic Disease Management Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Chronic Disease Management Service include Cognizant, Phytel, Pegasystems, EXL Healthcare, AxisPoint Health, Philips, HCSC, i2i Systems and HealthSmart Holdings, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chronic Disease Management Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Chronic Disease Management Service by region & country, by Type, and by Application.
The Chronic Disease Management Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Disease Management Service.
麻豆原创 Segmentation
By Company
Cognizant
Phytel
Pegasystems
EXL Healthcare
AxisPoint Health
Philips
HCSC
i2i Systems
HealthSmart Holdings
Allscripts
ZeOmega
Harmony Information Systems
Segment by Type:
Cloud-Based
On-Premise
Segment by Application
Rehabilitation Centers
Long-term Care Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chronic Disease Management Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Chronic Disease Management Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Chronic Disease Management Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Chronic Disease Management Service Product Introduction
1.2 Global Chronic Disease Management Service 麻豆原创 Size Forecast
1.3 Chronic Disease Management Service 麻豆原创 Trends & Drivers
1.3.1 Chronic Disease Management Service Industry Trends
1.3.2 Chronic Disease Management Service 麻豆原创 Drivers & Opportunity
1.3.3 Chronic Disease Management Service 麻豆原创 Challenges
1.3.4 Chronic Disease Management Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chronic Disease Management Service Players Revenue Ranking (2023)
2.2 Global Chronic Disease Management Service Revenue by Company (2019-2024)
2.3 Key Companies Chronic Disease Management Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Chronic Disease Management Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Chronic Disease Management Service
2.6 Chronic Disease Management Service 麻豆原创 Competitive Analysis
2.6.1 Chronic Disease Management Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Chronic Disease Management Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Disease Management Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cloud-Based
3.1.2 On-Premise
3.2 Global Chronic Disease Management Service Sales Value by Type
3.2.1 Global Chronic Disease Management Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Chronic Disease Management Service Sales Value, by Type (2019-2030)
3.2.3 Global Chronic Disease Management Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Rehabilitation Centers
4.1.2 Long-term Care Centers
4.1.3 Others
4.2 Global Chronic Disease Management Service Sales Value by Application
4.2.1 Global Chronic Disease Management Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Chronic Disease Management Service Sales Value, by Application (2019-2030)
4.2.3 Global Chronic Disease Management Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Chronic Disease Management Service Sales Value by Region
5.1.1 Global Chronic Disease Management Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Chronic Disease Management Service Sales Value by Region (2019-2024)
5.1.3 Global Chronic Disease Management Service Sales Value by Region (2025-2030)
5.1.4 Global Chronic Disease Management Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Chronic Disease Management Service Sales Value, 2019-2030
5.2.2 North America Chronic Disease Management Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Chronic Disease Management Service Sales Value, 2019-2030
5.3.2 Europe Chronic Disease Management Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Chronic Disease Management Service Sales Value, 2019-2030
5.4.2 Asia Pacific Chronic Disease Management Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Chronic Disease Management Service Sales Value, 2019-2030
5.5.2 South America Chronic Disease Management Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Chronic Disease Management Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Chronic Disease Management Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chronic Disease Management Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Chronic Disease Management Service Sales Value
6.3 United States
6.3.1 United States Chronic Disease Management Service Sales Value, 2019-2030
6.3.2 United States Chronic Disease Management Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Chronic Disease Management Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Chronic Disease Management Service Sales Value, 2019-2030
6.4.2 Europe Chronic Disease Management Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Chronic Disease Management Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Chronic Disease Management Service Sales Value, 2019-2030
6.5.2 China Chronic Disease Management Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Chronic Disease Management Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Chronic Disease Management Service Sales Value, 2019-2030
6.6.2 Japan Chronic Disease Management Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Chronic Disease Management Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Chronic Disease Management Service Sales Value, 2019-2030
6.7.2 South Korea Chronic Disease Management Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Chronic Disease Management Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Chronic Disease Management Service Sales Value, 2019-2030
6.8.2 Southeast Asia Chronic Disease Management Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Chronic Disease Management Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Chronic Disease Management Service Sales Value, 2019-2030
6.9.2 India Chronic Disease Management Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Chronic Disease Management Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cognizant
7.1.1 Cognizant Profile
7.1.2 Cognizant Main Business
7.1.3 Cognizant Chronic Disease Management Service Products, Services and Solutions
7.1.4 Cognizant Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.1.5 Cognizant Recent Developments
7.2 Phytel
7.2.1 Phytel Profile
7.2.2 Phytel Main Business
7.2.3 Phytel Chronic Disease Management Service Products, Services and Solutions
7.2.4 Phytel Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.2.5 Phytel Recent Developments
7.3 Pegasystems
7.3.1 Pegasystems Profile
7.3.2 Pegasystems Main Business
7.3.3 Pegasystems Chronic Disease Management Service Products, Services and Solutions
7.3.4 Pegasystems Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.3.5 EXL Healthcare Recent Developments
7.4 EXL Healthcare
7.4.1 EXL Healthcare Profile
7.4.2 EXL Healthcare Main Business
7.4.3 EXL Healthcare Chronic Disease Management Service Products, Services and Solutions
7.4.4 EXL Healthcare Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.4.5 EXL Healthcare Recent Developments
7.5 AxisPoint Health
7.5.1 AxisPoint Health Profile
7.5.2 AxisPoint Health Main Business
7.5.3 AxisPoint Health Chronic Disease Management Service Products, Services and Solutions
7.5.4 AxisPoint Health Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.5.5 AxisPoint Health Recent Developments
7.6 Philips
7.6.1 Philips Profile
7.6.2 Philips Main Business
7.6.3 Philips Chronic Disease Management Service Products, Services and Solutions
7.6.4 Philips Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.6.5 Philips Recent Developments
7.7 HCSC
7.7.1 HCSC Profile
7.7.2 HCSC Main Business
7.7.3 HCSC Chronic Disease Management Service Products, Services and Solutions
7.7.4 HCSC Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.7.5 HCSC Recent Developments
7.8 i2i Systems
7.8.1 i2i Systems Profile
7.8.2 i2i Systems Main Business
7.8.3 i2i Systems Chronic Disease Management Service Products, Services and Solutions
7.8.4 i2i Systems Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.8.5 i2i Systems Recent Developments
7.9 HealthSmart Holdings
7.9.1 HealthSmart Holdings Profile
7.9.2 HealthSmart Holdings Main Business
7.9.3 HealthSmart Holdings Chronic Disease Management Service Products, Services and Solutions
7.9.4 HealthSmart Holdings Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.9.5 HealthSmart Holdings Recent Developments
7.10 Allscripts
7.10.1 Allscripts Profile
7.10.2 Allscripts Main Business
7.10.3 Allscripts Chronic Disease Management Service Products, Services and Solutions
7.10.4 Allscripts Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.10.5 Allscripts Recent Developments
7.11 ZeOmega
7.11.1 ZeOmega Profile
7.11.2 ZeOmega Main Business
7.11.3 ZeOmega Chronic Disease Management Service Products, Services and Solutions
7.11.4 ZeOmega Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.11.5 ZeOmega Recent Developments
7.12 Harmony Information Systems
7.12.1 Harmony Information Systems Profile
7.12.2 Harmony Information Systems Main Business
7.12.3 Harmony Information Systems Chronic Disease Management Service Products, Services and Solutions
7.12.4 Harmony Information Systems Chronic Disease Management Service Revenue (US$ Million) & (2019-2024)
7.12.5 Harmony Information Systems Recent Developments
8 Industry Chain Analysis
8.1 Chronic Disease Management Service Industrial Chain
8.2 Chronic Disease Management Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chronic Disease Management Service Sales Model
8.5.2 Sales Channel
8.5.3 Chronic Disease Management Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Cognizant
Phytel
Pegasystems
EXL Healthcare
AxisPoint Health
Philips
HCSC
i2i Systems
HealthSmart Holdings
Allscripts
ZeOmega
Harmony Information Systems

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.